Cerus Corporation - Common Stock — Bilan (NASDAQ:CERS)

Afficher le graphique complet Full chart

Financials

Total de l'actif 221.41 M237.5 M218.09 M197.75 M200.92 M221.86 M Total du passif 117.61 M151.88 M149.53 M144.3 M144.02 M156.89 M Total des capitaux propres 103.81 M85.62 M68.56 M53.44 M56.9 M64.97 M Total du passif et des capitaux propres 221.41 M237.5 M218.09 M197.75 M200.92 M221.86 M Dette totale 48.1 M69.42 M69.8 M79.8 M84.16 M83.89 M Dette nette -85.49 M-59.94 M-32.35 M13.94 M3.71 M1.01 M

Cerus Corporation - Common Stock

Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry.

CERS

Financials

Cerus Corporation - Common Stock

Nouvelles

Cerus Corporation: Strong Q1 Results Validate The Turnaround Thesis (NASDAQ:CERS)

Top 3 Health Care Stocks That May Collapse This Month - Apellis Pharmaceuticals (NASDAQ:APLS), Avanos Med

Cerus Corporation (CERS) Q1 2026 Earnings Call Transcript

Jensen, directrice juridique de Cerus Corp, vend pour 187.000$ d’actions

Jensen, Cerus Corp chief legal officer, sells $187k in stock

Le directeur financier de Cerus Corp vend pour 211.000$ d’actions

Cerus Corp : le directeur médical Benjamin vend pour 168.000$ d’actions

Le COO de Cerus Corp, Jayaraman, vend pour 273.000$ d’actions

Le PDG de Cerus Corp, Greenman, vend pour 742.000$ d’actions

Cerus Corp COO Jayaraman sells $273k in shares

Cerus Corp CEO Greenman sells $742k in shares

Cerus Corp CFO green sells $211k in shares